Europe
Mine Güner discusses bridging law and business, taking the initiative, and why Taylor Swift helped put copyright on the map
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
As UPC activity continues to drive strategic hiring and expansion, recent rulings have delivered a notable win for Samsung, and further uncertainty in the long-running GSK-Pfizer vaccine battle
Sponsored
Sponsored
-
Sponsored by Patrinos & KilimirisMaria Kilimiris of Patrinos & Kilimiris considers how the EUIPO and Greek courts decided on a trademark dispute on the content of pharma goods -
Sponsored by Patrinos & KilimirisEvangelia Sioumala of Patrinos & Kilimiris looks at a recent judgment that examines the applicability of Regulations 1215/2012 and 2017/1001 when it comes to entities domiciliated in UK, following Brexit
-
Sponsored by MaiwaldStefanie Parchmann of Maiwald considers the long-awaited referral to the Enlarged Board of Appeal regarding plausibility
-
Sponsored by MaiwaldDr Gisela Grabow of Maiwald explains the importance of a comprehensive approach to the revision of pharmaceutical legislation that considers the relationship with IP rights and the Action Plan on IP
-
Sponsored by Bird & BirdChris de Mauny of Bird & Bird discusses the current and future importance of sufficiency in light of recent UK case law
-
Sponsored by Gün + PartnersAysel Korkmaz Yatkin and Aysu Eryaşar of Gun and Partners evaluate the position of Turkey’s IP courts in a case focusing on preliminary injunction assessments
European Jurisdictions